Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-27

FDA Approved: DAPSONE — Original Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved the original application for DAPSONE (dapsone) as a generic drug from Alembic Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DAPSONE (dapsone)

Snippet

ORIG AP for DAPSONE (DAPSONE)